Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension

American Journal of Pathology

Volumn 182, Issue 6, 2013, Pages 2391-2406

  Ghatnekar, Angela ^a   Chrobak, Izabela ^b   Reese, Charlie ^a   Stawski, Lukasz ^b   Seta, Francesca ^b   Wirrig, Elaine ^a,b   Paez Cortez, Jesus ^b   Markiewicz, Margaret ^a   Asano, Yoshihide ^a   Harley, Russell ^a   Silver, Richard ^a   Feghali Bostwick, Carol ^c   Trojanowska, Maria ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE EXPRESSION; GRANULOCYTE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IDIOPATHIC DISEASE; INFLAMMATION; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SYSTEMIC SCLEROSIS; VASCULAR SMOOTH MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANOXIA; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CHRONIC DISEASE; DISEASE PROGRESSION; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GATA6 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; LUNG; MALE; MICE; MICE, KNOCKOUT; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SCLERODERMA, SYSTEMIC;

EID: 84878247052     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.02.039     Document Type: Article

References (47)

1. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, C.G. Elliott, S.P. Gaine, M.T. Gladwin, Z.C. Jing, M.J. Krowka, D. Langleben, N. Nakanishi, and R. Souza Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
2. M.R. Fisher, S.C. Mathai, H.C. Champion, R.E. Girgis, T. Housten-Harris, L. Hummers, J.A. Krishnan, F. Wigley, and P.M. Hassoun Clinical differences between idiopathic and scleroderma-related pulmonary hypertension Arthritis Rheum 54 2006 3043 3050
3. S.Y. Chan, and J. Loscalzo Pathogenic mechanisms of pulmonary arterial hypertension J Mol Cell Cardiol 44 2008 14 30
4. The International PPH Consortium K.B. Lane, R.D. Machado, M.W. Pauciulo, J.R. Thomson, J.A. Phillips 3rd, J.E. Loyd, W.C. Nichols, and R.C. Trembath Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension Nat Genet 26 2000 81 84
5. M. Mahmoud, G.M. Borthwick, A.A. Hislop, and H.M. Arthur Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH Lab Invest 89 2009 15 25
6. K.H. Hong, Y.J. Lee, E. Lee, S.O. Park, C. Han, H. Beppu, E. Li, M.K. Raizada, K.D. Bloch, and S.P. Oh Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension Circulation 118 2008 722 730
7. J. Morse, R. Barst, E. Horn, N. Cuervo, Z. Deng, and J. Knowles Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations J Rheumatol 29 2002 2379 2381
8. A. Selva-O'Callaghan, E. Balada, S. Serrano-Acedo, C.P. Simeon Aznar, and J. Ordi-Ros Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease Clin Rheumatol 26 2007 947 949
9. J. Le Pavec, M. Humbert, L. Mouthon, and P.M. Hassoun Systemic sclerosis-associated pulmonary arterial hypertension Am J Respir Crit Care Med 181 2010 1285 1293
10. E. Hsu, H. Shi, R.M. Jordan, J. Lyons-Weiler, J.M. Pilewski, and C.A. Feghali-Bostwick Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension Arthritis Rheum 63 2011 783 794
11. J.D. Molkentin The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression J Biol Chem 275 2000 38949 38952
12. E. Suzuki, T. Evans, J. Lowry, L. Truong, D.W. Bell, J.R. Testa, and K. Walsh The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals Genomics 38 1996 283 290
13. W. Nishida, M. Nakamura, S. Mori, M. Takahashi, Y. Ohkawa, S. Tadokoro, K. Yoshida, K. Hiwada, K. Hayashi, and K. Sobue A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes J Biol Chem 277 2002 7308 7317
14. H. Wada, K. Hasegawa, T. Morimoto, T. Kakita, T. Yanazume, and S. Sasayama A p300 protein as a coactivator of GATA-6 in the transcription of the smooth muscle-myosin heavy chain gene J Biol Chem 275 2000 25330 25335
15. T. Mano, Z. Luo, S.L. Malendowicz, T. Evans, and K. Walsh Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery Circ Res 84 1999 647 654
16. A. Ghatnekar, and M. Trojanowska GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts Biochim Biophys Acta 1779 2008 145 151
17. K.N. Cowan, P.L. Jones, and M. Rabinovitch Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease J Clin Invest 105 2000 21 34
18. M. Kubo, S. Umemoto, K. Fujii, S. Itoh, M. Tanaka, S. Kawahara, and M. Matsuzaki Effects of angiotensin II type 1 receptor antagonist on smooth muscle cell phenotype in intramyocardial arteries from spontaneously hypertensive rats Hypertens Res 27 2004 685 693
19. B. Liu, X.Q. Wang, L. Yu, T.F. Zhou, X.M. Wang, and H.M. Liu Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats Exp Lung Res 35 2009 411 426
20. N. Froese, B. Kattih, A. Breitbart, A. Grund, R. Geffers, J.D. Molkentin, A. Kispert, K.C. Wollert, H. Drexler, and J. Heineke GATA6 promotes angiogenic function and survival in endothelial cells by suppression of autocrine transforming growth factor beta/activin receptor-like kinase 5 signaling J Biol Chem 286 2011 5680 5690
21. B. Giusti, G. Fibbi, F. Margheri, S. Serrati, L. Rossi, F. Poggi, I. Lapini, A. Magi, A. Del Rosso, M. Cinelli, S. Guiducci, B. Kahaleh, L. Bazzichi, S. Bombardieri, M. Matucci-Cerinic, G.F. Gensini, M. Del Rosso, and R. Abbate A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients Arthritis Res Ther 8 2006 R115
22. E.E. Wirrig, B.S. Snarr, M.R. Chintalapudi, J.L. O'Neal, A.L. Phelps, J.L. Barth, V.M. Fresco, C.B. Kern, C.H. Mjaatvedt, B.P. Toole, S. Hoffman, T.C. Trusk, W.S. Argraves, and A. Wessels Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development Dev Biol 310 2007 291 303
23. F. Shirasaki, H.A. Makhluf, C. LeRoy, D.K. Watson, and M. Trojanowska Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter Oncogene 18 1999 7755 7764
24. S.S. Nakerakanti, B. Kapanadze, M. Yamasaki, M. Markiewicz, and M. Trojanowska Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program J Biol Chem 281 2006 25259 25269
25. R. Summer, C.A. Fiack, Y. Ikeda, K. Sato, D. Dwyer, N. Ouchi, A. Fine, H.W. Farber, and K. Walsh Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease Am J Physiol Lung Cell Mol Physiol 297 2009 L432 L438
26. W. Steudel, F. Ichinose, P.L. Huang, W.E. Hurford, R.C. Jones, J.A. Bevan, M.C. Fishman, and W.M. Zapol Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene Circ Res 81 1997 34 41
27. N.W. Morrell, S. Adnot, S.L. Archer, J. Dupuis, P.L. Jones, M.R. MacLean, I.F. McMurtry, K.R. Stenmark, P.A. Thistlethwaite, N. Weissmann, J.X. Yuan, and E.K. Weir Cellular and molecular basis of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S20 S31
28. H.B. Thibault, B. Kurtz, M.J. Raher, R.S. Shaik, A. Waxman, G. Derumeaux, E.F. Halpern, K.D. Bloch, and M. Scherrer-Crosbie Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension Circ Cardiovasc Imaging 3 2010 157 163
29. K.A. Fagan, B.W. Fouty, R.C. Tyler, K.G. Morris Jr., L.K. Hepler, K. Sato, T.D. LeCras, S.H. Abman, H.D. Weinberger, P.L. Huang, I.F. McMurtry, and D.M. Rodman The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia J ClinI Invest 103 1999 291 299
30. A. Giaid, and D. Saleh Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 1995 214 221
31. D. Shao, J.E. Park, and S.J. Wort The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension Pharmacol Res 63 2011 504 511
32. S.W. Allen, B.A. Chatfield, S.A. Koppenhafer, M.S. Schaffer, R.R. Wolfe, and S.H. Abman Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity Am Rev Respir Dis 148 1993 519 522
33. A. Giaid, M. Yanagisawa, D. Langleben, R.P. Michel, R. Levy, H. Shennib, S. Kimura, T. Masaki, W.P. Duguid, and D.J. Stewart Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 1732 1739
34. P. Calabro, G. Limongelli, V. Maddaloni, C.D. Vizza, M. D'Alto, R. D'Alessandro, R. Poscia, P. Argiento, B. Ziello, R. Badagliacca, E. Romeo, G. Pacileo, M.G. Russo, F. Fedele, and R. Calabro Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension Intern Emerg Med 7 2012 425 430
35. P. Crosswhite, and Z. Sun Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension J Hypertens 28 2010 201 212
36. P.M. Hassoun, L. Mouthon, J.A. Barbera, S. Eddahibi, S.C. Flores, F. Grimminger, P.L. Jones, M.L. Maitland, E.D. Michelakis, N.W. Morrell, J.H. Newman, M. Rabinovitch, R. Schermuly, K.R. Stenmark, N.F. Voelkel, J.X. Yuan, and M. Humbert Inflammation, growth factors, and pulmonary vascular remodeling J Am Coll Cardiol 54 2009 S10 S19
37. M. Humbert, N.W. Morrell, S.L. Archer, K.R. Stenmark, M.R. MacLean, I.M. Lang, B.W. Christman, E.K. Weir, O. Eickelberg, N.F. Voelkel, and M. Rabinovitch Cellular and molecular pathobiology of pulmonary arterial hypertension J Am Coll Cardiol 43 2004 13S 24S
38. J. Zhang, and J.M. Patel Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases Int J Clin Exp Med 3 2010 233 244
39. K. Balabanian, A. Foussat, P. Dorfmuller, I. Durand-Gasselin, F. Capel, L. Bouchet-Delbos, A. Portier, A. Marfaing-Koka, R. Krzysiek, A.C. Rimaniol, G. Simonneau, D. Emilie, and M. Humbert CX(3)C chemokine fractalkine in pulmonary arterial hypertension Am J Respir Crit Care Med 165 2002 1419 1425
40. B. Chandrasekar, S. Mummidi, R.P. Perla, S. Bysani, N.O. Dulin, F. Liu, and P.C. Melby Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway Biochem J 373 2003 547 558
41. J. Ryu, C.W. Lee, K.H. Hong, J.A. Shin, S.H. Lim, C.S. Park, J. Shim, K.B. Nam, K.J. Choi, Y.H. Kim, and K.H. Han Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia Cardiovasc Res 78 2008 333 340
42. K. Yamashita, T. Imaizumi, M. Hatakeyama, W. Tamo, D. Kimura, M. Kumagai, H. Yoshida, and K. Satoh Effect of hypoxia on the expression of fractalkine in human endothelial cells Tohoku J Exp Med 200 2003 187 194
43. O.P. Radmark The molecular biology and regulation of 5-lipoxygenase Am J Respir Crit Care Med 161 2000 S11 S15
44. N.F. Voelkel, R.M. Tuder, K. Wade, M. Hoper, R.A. Lepley, J.L. Goulet, B.H. Koller, and F. Fitzpatrick Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats J Clin Invest 97 1996 2491 2498
45. L. Wright, R.M. Tuder, J. Wang, C.D. Cool, R.A. Lepley, and N.F. Voelkel 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension Am J Respir Crit Care Med 157 1998 219 229
46. L.C. Price, S.J. Wort, F. Perros, P. Dorfmuller, A. Huertas, D. Montani, S. Cohen-Kaminsky, and M. Humbert Inflammation in pulmonary arterial hypertension Chest 141 2012 210 221
47. M. Koenig, F. Joyal, M.J. Fritzler, A. Roussin, M. Abrahamowicz, G. Boire, J.R. Goulet, E. Rich, T. Grodzicky, Y. Raymond, and J.L. Senecal Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis Arthritis Rheum 58 2008 3902 3912